Localization of thymosin β-4 in tumors

Annals of the New York Academy of Sciences

Volumn 1112, Issue , 2007, Pages 317-325

  Larsson, Lars Inge ^a   Holck, Susanne ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Breast; Cancer; Colorectal; Endothelial cells; Macrophages; Thymosin 4

Indexed keywords

NITROBLUE TETRAZOLIUM; POLYPEPTIDE; THYMOSIN BETA4;

BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER LOCALIZATION; CELL COUNT; CELL HETEROGENEITY; COLORECTAL CARCINOMA; CONFERENCE PAPER; ENDOTHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; NITROBLUE TETRAZOLIUM TEST; PROTEIN LOCALIZATION; PROTEIN SECRETION;

EID: 35348986942     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1415.005     Document Type: Conference Paper

References (34)

1. BALLWEBER, E. et al. 2002. Polymerization of chemically cross-linked actin: thymosin beta(4) complex to filamentous actin: alterations in helical parameters and visualization of thymosin beta(4) binding on F-actin. J. Mol. Biol. 315: 613-625.
2. SANDERS, M.C., A.L. GOLDSTEIN & Y.L. WANG. 1992. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc. Natl. Acad. Sci. USA 89: 4678-4682.
3. CHA, H.J., M.J. JEONG & H.K. KLEINMAN. 2003. Role of thymosin beta4 in tumor metastasis and angiogenesis. J. Natl. Cancer Inst. 95: 1674-1680.
4. KOUTRAFOURI, V. et al. 2001. Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. Biochim. Biophys. Acta 1568: 60-66.
5. MALINDA, K.M. et al. 1999. Thymosin beta4 accelerates wound healing. J. Invest. Dermatol. 113:364-368.
6. PHILP, D. et al. 2003. Thymosin beta4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair. Regen. 11: 19-24.
7. BADAMCHIAN, M. et al. 2003. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int. Immunopharmacol. 3: 1225-1233.
8. SOSNE, G. et al. 2001 Thymosin beta4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 72: 605-608.
9. SOSNE, G. et al. 2002. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp. Eye Res. 74: 293-299.
10. YOUNG, J.D. et al. 1999. Thymosinbeta4 sulfoxide is an antiinflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med. 5: 1424-1427.
11. BOCK-MARQUETTE, I. et al. 2004. Thymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432: 466-472.
12. CLARK, E.A. et al. 2000. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535.
13. JI, P. et al. 2003. MALAT-1, a novel noncoding RNA and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 6087-6097.
14. KOBAYASHI, T. et al. 2002. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am. J. Pathol. 160: 869-882.
15. OTTO, A.M. et al. 2002. Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells. J. Cancer Res. Clin. Oncol. 128: 247-256.
16. WANG, W.S. et al. 2003. Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 22: 3297-3306.
17. WANG, W.S. et al. 2004. Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 23: 6666-6671.
18. YAMAMOTO, T. et al. 1993. Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas. Bichem. Biophys. Res. Commun. 193: 706-710.
19. HANNAPPEL, E. et al. 1982. Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues. Proc. Natl. Acad. Sci. USA 79: 2172-2175.
20. HUFF, T. et al. 2001. Beta-thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 33: 205-220.
21. GONDO, H. et al. 1987. Differential expression of the thymosin-beta 4 gene in lymphocytes, macrophages and granulocytes. J. Immunol. 139: 3840-3848.
22. HANNAPPEL, E. & M. VAN KAMPEN. 1987. Determination of thymosin beta 4 in human blood cells and serum. J. Chromatogr. 397: 279-285.
23. XU, G. et al. 1982. Synthesis of thymosin beta 4 by peritoneal macrophages and adherent spleen cells. Proc. Natl. Acad. Sci. USA 79: 4006-4009.
24. FROHM, M. et al. 1996. Biochemical and antibacterial analysis of human wound and blister fluid. Eur. J. Biochem. 237: 86-92.
25. DATHE, V. & B. BRAND-SABERI. 2004. Expression of thymosin beta4 during chick development. Anat. Embryol. 208: 27-32.
26. GOMEZ-MARQUEZ, J. et al. 1996. High levels of thymosin beta4 mRNA in differentiating P19 embryonic cells and during development of cardiovascular tissues. Biochim. Biophys. Acta 1306: 187-193.
27. GRANT, D.S. et al. 1999. Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3:125-135.
28. LARSSON, L.-I. & S. HOLCK 2007. Occurrence of thymosin beta-4 in human breast cancer cells and in other cell types of the tumor microenvironment. Human Pathol. 38: 114-119.
29. LARSSON, L.-I. 1988. Immunocytochemistry. Theory and Practice. CRC Press. Boca Raton, FL.
30. ELSTON, C.W. & I.O. ELLIS. 1998. Assessment of histological grade. In Systematic Pathology, 3rd ed, Vol 13. The Breast. C.W. Elston & I.O. Ellis, Eds.: 365-377. Churchill Livingstone. Edinburgh.
31. GOLDSTEIN, A.L., E. HANNAPPEL & H.K. KLEINMAN. 2005. Thymosin beta-4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 9: 421-429.
32. HO, J.H. et al. 2007. Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 48: 27-33.
33. OH, S.Y. et al. 2006. ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel resistance. Exp. Cell Res. 312: 1651-1657.
34. SOSNE, G. et al. Thymosin beta-4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro. Exp. Eye Res. 83: 502-507.